| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50378 |
FLS5 |
mouse |
liver |
Mouse liver stromal cell line. |
|
| 2 | general cells |
IFO50476 |
NKM-1 |
human |
peripheral blood |
leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth |
|
| 3 | general cells |
JCRB0001 |
F9-41 |
mouse |
testis |
Mouse testicular teratocarcinoma cell line. |
|
| 4 | general cells |
JCRB0024 |
IM-9 |
human |
bone marrow |
myeloma, multiple, B lymphoblastic |
|
| 5 | general cells |
JCRB0097 |
A4/Fuk |
human |
ascites |
lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing |
|
| 6 | general cells |
JCRB0153.3 |
tsJT60 |
rat |
embryo |
Rat 3Y1 derived ts mutant cell line with cell cycle arrest at G0 phase. |
|
| 7 | general cells |
JCRB0220 |
NTI-4 |
human |
fetus body |
Normal human fibroblast. |
|
| 8 | general cells |
JCRB0412 |
AH70Btc |
rat |
liver |
ascites hepatoma, (Donryu rat) |
|
| 9 | general cells |
JCRB0416 |
Ac2F(DT) |
rat |
liver transformed |
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat) |
|
| 10 | general cells |
JCRB0540 |
TIG-119 |
human |
skin |
Normal human diploid cell from skin. |
|
| 11 | general cells |
JCRB0542 |
TIG-120 |
human |
skin |
Normal diploid fibroblast from human skin with limited lifespan. |
|
| 12 | general cells |
JCRB1006.8F |
OUMS-36T-8F |
human |
embryo |
fibroblast, immortalized by hTRT, derivative of OUMS-36 |
|
| 13 | general cells |
JCRB1024 |
Kasumi-6 |
human |
peripheral blood |
Human acute myeloid leukemia cell line with dominant negative mutation in the C/EBP alpha gene. |
|
| 14 | general cells |
JCRB1099 |
hs-172-3 |
hamster, Chinese |
lung |
Temperature sensitive mutant of Chines hamster lung cell line. |
|
| 15 | general cells |
JCRB1101 |
hs-222-3 |
hamster, Chinese |
lung |
temperature sensitive mutant of Chinese hamster lung cell line. |
|
| 16 | general cells |
JCRB1123 |
HEC-108 |
human |
uterine corpus |
Human tumor cell line from uterine endometrium. |
|
| 17 | general cells |
JCRB1141 |
HEC-251 |
human |
uterine corpus |
Human endometrial carcinoma from uterus body. |
|
| 18 | general cells |
JCRB1213.1 |
DIG64.2B.5 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against digoxin. |
|
| 19 | general cells |
JCRB1214 |
NCC-RbC-67 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. The growth is extremely slow. |
|
| 20 | general cells |
JCRB1342.01 |
MOR8.2.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 21 | general cells |
JCRB1441 |
ASF-4-4L1 |
human |
skin |
Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
|
| 22 | genetically-modified cells |
JCRB1572 |
HAdpc-28-E6E7-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
| 23 | general cells |
JCRB1807 |
MOLM-6 |
human |
|
Human multiple leukemia cell line with diverse myeloid and/or megakaryoblastic characteristics |
|
| 24 | genetically-modified cells |
JCRB1992 |
HeLa/Blvra KO |
human |
uterine cervix |
HeLa cells deficient in biliverdin reductase A |
|
| 25 | general cells |
JCRB9046 |
GH1 |
rat |
pituitary gland |
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) |
|
| 26 | general cells |
JCRB9067 |
NRK-49F |
rat |
kidney |
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat) |
|
| 27 | general cells |
JCRB9069 |
SW-13 |
human |
adrenal cortex |
Human adenocarcinoma derived from adrenal cortex. |
|
| 28 | general cells |
JCRB9099 |
SV-T2 |
mouse |
embryo |
SV40 virus-transformed BALB/3T3, (BALB/c mouse) |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.